The Delhi High Court has observed that it would be unwise to allow expansion of “offshore study centres” which are running without necessary approvals from the authorities as it could flourish a.
While only slightly past the midway point of 2023, it has already been a busy year for developments in drug pricing. Notably, CMS released its final guidance in preparation for price.